Dongwha wins USA patent for its antibiotic of multidrug-resistant bacteria
Published: 2004-08-27 06:56:00
Updated: 2004-08-27 06:56:00
Dongwha Pharm said that it recently won from the United States a patent relating to photoactive 7-pyrrolidine quinoline carboxyl acid derivative and its manufacturing method for the treatment of methicillin-resistant or quinoline-resistant bacteria.
The photoactive naphtylidine derivative is a...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
